110 related articles for article (PubMed ID: 10879239)
1. Steroid-induced osteoporosis--a cause for concern?
Tan TT; Lau IS; Kong NC; Zainal AG
Malays J Pathol; 1997 Jun; 19(1):27-33. PubMed ID: 10879239
[No Abstract] [Full Text] [Related]
2. Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.
Van Staa TP; Laan RF; Barton IP; Cohen S; Reid DM; Cooper C
Arthritis Rheum; 2003 Nov; 48(11):3224-9. PubMed ID: 14613287
[TBL] [Abstract][Full Text] [Related]
3. [Alendronate prevents steroid-induced osteoporosis in patients with rheumatic diseases].
Wang QH; Wu HX; Huang YL; Xue J; Yang XY; Zhu L; Wen LH
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(27):1888-91. PubMed ID: 19040000
[TBL] [Abstract][Full Text] [Related]
4. [Bone mineral density in idiopathic inflammatory myopathies].
Antelava OA; Smirnov AV; Demin NV; Khitrov AN; Benevolenskaia LI; Nasonov EL
Klin Med (Mosk); 2003; 81(2):57-61. PubMed ID: 12685239
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in premenopausal women with systemic lupus erythematosus.
Uaratanawong S; Deesomchoke U; Lertmaharit S; Uaratanawong S
J Rheumatol; 2003 Nov; 30(11):2365-8. PubMed ID: 14677178
[TBL] [Abstract][Full Text] [Related]
6. [Secondary osteoporosis. Glucocorticoid-induced osteoporosis: Threshold of bone mineral density for vertebral fracture].
Soen S
Clin Calcium; 2007 Mar; 17(3):399-402. PubMed ID: 17339745
[TBL] [Abstract][Full Text] [Related]
7. New developments in the pathogenesis and treatment of steroid-induced osteoporosis.
Manolagas SC; Weinstein RS
J Bone Miner Res; 1999 Jul; 14(7):1061-6. PubMed ID: 10404005
[No Abstract] [Full Text] [Related]
8. Inhaled triamcinolone and chronic obstructive pulmonary disease.
Lipworth BJ; Jackson CM
N Engl J Med; 2001 May; 344(20):1553; author reply 1554-6. PubMed ID: 11368046
[No Abstract] [Full Text] [Related]
9. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
Li CY; Jee WS; Chen JL; Mo A; Setterberg RB; Su M; Tian XY; Ling YF; Yao W
Calcif Tissue Int; 2003 Jan; 72(1):42-9. PubMed ID: 12370795
[TBL] [Abstract][Full Text] [Related]
10. The effect of long-term glucocorticoids on bone metabolism in systemic lupus erythematosus patients: the prevalence of its anti-inflammatory action upon bone resorption.
Korczowska I; Olewicz-Gawlik A; Hrycaj P; Lacki J
Yale J Biol Med; 2003; 76(2):45-54. PubMed ID: 15369631
[TBL] [Abstract][Full Text] [Related]
11. Bone mineral density changes in women with systemic lupus erythematosus.
Boyanov M; Robeva R; Popivanov P
Clin Rheumatol; 2003 Oct; 22(4-5):318-23. PubMed ID: 14579164
[TBL] [Abstract][Full Text] [Related]
12. Secondary osteoporosis in liver transplant recipients: a longitudinal study in patients with and without cholestatic liver disease.
Bjøro K; Brandsaeter B; Wiencke K; Bjøro T; Godang K; Bollerslev J; Schrumpf E
Scand J Gastroenterol; 2003 Mar; 38(3):320-7. PubMed ID: 12737449
[TBL] [Abstract][Full Text] [Related]
13. [Active vitamin D3 therapy for gulucocorticoid-induced osteoporosis].
Nakayama H
Clin Calcium; 2006 Jul; 16(7):1201-7. PubMed ID: 16816482
[TBL] [Abstract][Full Text] [Related]
14. Effects of prasterone on bone mineral density in women with active systemic lupus erythematosus receiving chronic glucocorticoid therapy.
Sánchez-Guerrero J; Fragoso-Loyo HE; Neuwelt CM; Wallace DJ; Ginzler EM; Sherrer YR; McIlwain HH; Freeman PG; Aranow C; Petri MA; Deodhar AA; Blanton E; Manzi S; Kavanaugh A; Lisse JR; Ramsey-Goldman R; McKay JD; Kivitz AJ; Mease PJ; Winkler AE; Kahl LE; Lee AH; Furie RA; Strand CV; Lou L; Ahmed M; Quarles B; Schwartz KE
J Rheumatol; 2008 Aug; 35(8):1567-75. PubMed ID: 18634158
[TBL] [Abstract][Full Text] [Related]
15. Does alendronate treatment prevent vertebral fractures in men with osteoporosis?
Li I
J Fam Pract; 2000 Dec; 49(12):1077. PubMed ID: 11132054
[No Abstract] [Full Text] [Related]
16. An update on glucocorticoid-induced osteoporosis.
Woolf AD
Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
[TBL] [Abstract][Full Text] [Related]
17. Steroid-induced osteoporosis in systemic lupus erythematosus.
Cunnane G; Lane NE
Rheum Dis Clin North Am; 2000 May; 26(2):311-29, vi-vii. PubMed ID: 10768214
[TBL] [Abstract][Full Text] [Related]
18. Osteoporosis treatment in elderly hyperthyroid male patients.
Fittipaldi MR; Fonderico F; Vitale G; Ciccarelli A; Lupoli GA; Cascella T; Panico A; Lupoli G
J Endocrinol Invest; 2002; 25(10 Suppl):98-100. PubMed ID: 12508936
[No Abstract] [Full Text] [Related]
19. The effect of systemic lupus erythematosus and long-term steroid therapy on bone mass in pre-menopausal women.
Pons F; Peris P; Guañabens N; Font J; Huguet M; Espinosa G; Ingelmo M; Muñoz-Gomez J; Setoain J
Br J Rheumatol; 1995 Aug; 34(8):742-6. PubMed ID: 7551659
[TBL] [Abstract][Full Text] [Related]
20. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
